Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm
Transplant International · 11.11.2024 · 37
DOI: 10.3389/ti.2024.13523 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 11.11.2024. Verfasst von Xavier Charmetant und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, U…. Hauptthemen laut MEDLINE: Graft Rejection, Killer Cells, Natural. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In transplantation, genetic differences between donor and recipient trigger immune responses that cause graft rejection. Allorecognition, the process by which the immune system discriminates allogeneic grafts, targets major histocompatibility complex (MHC) and minor histocompatibility antigens. Historically, it was believed that allorecognition was solely mediated by the recipient’s adaptive immune system recognizing donor-specific alloantigens. However, recent research has shown significant roles for innate immune components, such as lymphoid and myeloid cells, which are sometimes triggered by the mere absence of a self-protein in the graft. This review integrates recent breakthroughs into the current allorecognition paradigm based on the well-established direct and indirect pathways, emphasizing the semi-direct pathway where recipient antigen-presenting cells (APCs) acquire donor MHC molecules, and the inverted direct pathway where donor CD4 + T cells within the graft activate recipient B cells to produce donor-specific antibodies (DSAs). The review also explores the role of natural killer (NK) cells in both promoting and inhibiting graft rejection, highlighting their dual role in innate allorecognition. Additionally, it discusses the emerging understanding of myeloid cell-mediated allorecognition and its implications for initiating adaptive immune responses. These insights aim to provide a more comprehensive understanding of allorecognition, potentially leading to improved transplant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre International de Recherche en Infectiologie, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR5308, Ecole Normale Supérieure de Lyon, University Lyon, Lyon, France.
- Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
- Lyon-Est Faculty of Medicine, Claude Bernard University (Lyon 1), Villeurbanne, France.
- Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
Zitieren
APA
Charmetant, X., Pettigrew, G. J., & Thaunat, O. (2024). Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm. Transplant International, 37. https://doi.org/10.3389/ti.2024.13523
Vancouver
Charmetant X, Pettigrew GJ, Thaunat O. Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm. Transplant International. 2024;37. doi:10.3389/ti.2024.13523
BibTeX
@article{Charmetant2024,
author = {Charmetant, Xavier and Pettigrew, Gavin J and Thaunat, Olivier},
title = {Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm},
journal = {Transplant International},
year = {2024},
volume = {37},
doi = {10.3389/ti.2024.13523}
}
EUVIMED